Yi-Ying Wu

Title: Yi-Ying Wu: Innovator in Neurodegeneration and Cancer Treatment

Introduction

Yi-Ying Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of neurodegeneration and cancer treatment, holding a total of 3 patents. His innovative work focuses on therapeutic strategies that target critical biological processes.

Latest Patents

One of his latest patents is titled "Nuclear paraspeckle assembly transcript 1 as therapeutic targeting in neurodegeneration." This patent outlines a method for reducing neurodegeneration and TDP43 associated aggregation by knocking down the expression of Nuclear Paraspeckle Assembly Transcript 1 (NEAT1) or LncRNA NEAT1. The patent also describes methods for screening candidate agents that can reduce neurodegeneration, treat or prevent neurodegenerative disorders, and assess the risk of developing such disorders through the measurement of cytoplasmic NEAT1 in biological samples.

Another significant patent is "Composition for treating cancer and use thereof." This invention provides a cyclic peptide containing the RRXR motif, along with a composition that includes this cyclic peptide and a pharmaceutical acceptable carrier. The patent further details a method for treating cancer using this composition.

Career Highlights

Yi-Ying Wu has worked at esteemed institutions such as National Taiwan University and Academia Sinica. His research and innovations have garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Yi-Ying Wu has collaborated with notable colleagues, including Pan-Chyr Yang and Tse-Ming Hong. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Yi-Ying Wu is a distinguished inventor whose work in neurodegeneration and cancer treatment has led to valuable patents and collaborations. His contributions continue to influence the fields of medicine and biotechnology.